Impact of selenium status on the pathogenesis of mycobacterial disease in HIV-1 - Infected drug users during the era of highly active antiretroviral therapy Article

Shor-Posner, G, Miguez, MJ, Pineda, LM et al. (2002). Impact of selenium status on the pathogenesis of mycobacterial disease in HIV-1 - Infected drug users during the era of highly active antiretroviral therapy . 29(2), 169-173. 10.1097/00042560-200202010-00010



cited authors

  • Shor-Posner, G; Miguez, MJ; Pineda, LM; Rodriguez, A; Ruiz, P; Castillo, G; Burbano, X; Lecusay, R; Baum, M

abstract

  • The risk of mycobacterial disease is significantly increased in drug abusers as well as in immunocompromised HIV-1-infected individuals. The essential trace element selenium has an important function in maintaining immune processes and may, thus, have a critical role in clearance of mycobacteria. The impact of selenium status on the development of mycobacterial diseases in HIV-1-seropositive drug users was investigated over a 2-year period (1999-2001). Twelve cases of mycobacterial disease (tuberculosis, 9; infection due to atypical Mycobacterium species, 3) occurred; these 12 cases were compared with 32 controls with no history of respiratory infections who were matched on age, sex, and HIV status. Significant risk for development of mycobacterial disease was associated with a CD4 cell count of <200/mm3, malnutrition, and selenium levels of ≤135 μg/L (patients with these levels were 13 times more likely to develop mycobacterial disease). Multivariate analyses controlling for antiretroviral treatment and CD4 cell count revealed that both body mass index and selenium level remained significant factors in the relative risk for developing mycobacterial disease (relative risk, 3; p = .015); these findings suggest that selenium status may have a profound impact on the pathogenesis of mycobacterial disease.

publication date

  • February 1, 2002

Digital Object Identifier (DOI)

start page

  • 169

end page

  • 173

volume

  • 29

issue

  • 2